SENTRY Synthetic Drug Early Warning and Response System

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form 1105-0087 SENTRY Synthetic Drug Early Warning and Response System	Form and Instruction	Modified	Available
Response to Terms of Clearance.doc	Supplementary Document	Uploaded 2011-01-06	Available
SENTRYUSER REGISTRATION FORM 010111.pdf	Supplementary Document	Uploaded 2011-01-04	Available
SENTRYUSER REGISTRATION FORM020910.pdf	Supplementary Document	Uploaded 2010-12-21	Available
SENTRY Submit Page.JPG	Supplementary Document	Uploaded 2010-12-21	Available
SENTRY Home Page.JPG	Supplementary Document	Uploaded 2010-12-21	Available
GPI Requirements Final_2010.xlsx	Supplementary Document	Uploaded 2010-10-29	Available
Public Law_LEXSEE 102 PL 396.rtf	Supplementary Document	Uploaded 2007-07-24	Available
SENTRYSupportingStatement_AddendumAddlInfoFinal_11302010.doc	Supporting Statement A	Uploaded 2011-01-04	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
181248	SENTRY Synthetic Drug Early Warning and Response System	Form and Instruction	Modified

ICR Details

OMB Control No: 1105-0087	ICR Reference No: 201008-1105-002
Status: Historical Active	Previous ICR Reference No: 200707-1105-001
Agency/Subagency: DOJ/LA	Agency Tracking No:
Title: SENTRY Synthetic Drug Early Warning and Response System
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 01/06/2011
	Date Received in OIRA: 10/29/2010
Terms of Clearance: DOJ did not comply with the previous terms of clearance of providing updates to OMB regarding implementation of SENTRY. These terms of clearance continue to apply for the next submission: DOJ will provide updates to OMB regarding the implementation of SENTRY. Specifically, it will report on the effectiveness of the program to mitigate the impact of synthetic drugs in the US. Going forward, DOJ will also provide detailed information on who is using the information, and what they are using it for.

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2013	36 Months From Approved	01/31/2011
Responses	300	0	300
Time Burden (Hours)	75	0	75
Cost Burden (Dollars)	0	0	0

---

Abstract: SENTRY/Emerging Drug Tracking System is an internet-based collection and dissemination system designed to help identify new syntetic drug-related behaviors at an early stage, evaluate their importance, and track their development. The ultimate goal of SENTRY is to inform and alert the counterdrug community to address problems at an early stage.

---

Authorizing Statute(s): PL: Pub.L. 102 - 396 9078 Name of Law: Department of Defense Appropriations Act, 1993
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 49946	08/16/2010
30-day Notice:	Federal Register Citation:	Citation Date:
	75 FR 62857	10/13/2010
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
SENTRY Synthetic Drug Early Warning and Response System	1105-0087, 1105-0087, 1105-0087, 1105-0087, xxxx	SENTRY Requirements (Exhibits) ,   SENTRY Requirements ,   SENTRY Source Identification Table ,   SENTRY User Account Table ,   SENTRY User Registration Form

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	300	300	0	0	0	0
Annual Time Burden (Hours)	75	75	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $115,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 10/29/2010

---